Publicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (5)

2021

  1. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 9, pp. 1137-1146

2019

  1. A Phase II Trial of Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

    Arthritis and Rheumatology, Vol. 71, Núm. 7, pp. 1056-1069

2018

  1. Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

    Rheumatology and Therapy, Vol. 5, Núm. 2, pp. 567-582

2014

  1. Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis

    Arthritis and Rheumatology, Vol. 66, Núm. 11, pp. 2924-2937

2012

  1. Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: The phase III FILM trial

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 8, pp. 1289-1296